Clinical Trials › NCT06345157
Active, Not Recruiting
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Sponsored by Novartis Pharmaceuticals
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 379
Target enrollment
Jul 2024
Start date
Jun 2026
Expected completion
Interventions / Treatments
Ofatumumab
Conditions studied
Multiple Sclerosis, Relapsing-Remitting
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
The app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.